Crestone presents two posters at Keystone Symposia (Santa Fe, NM).
- Optimization and Lead Selection of Benzothiazole-adamantyl Amide Analogs toward a Novel Antimycobacterial Agent
- Phase 1 Clinical Trial Results on the Safety and Pharmacokinetics of CRS3123, a Novel Narrow-Spectrum Agent in Development to Treat C. difficile Infections